Cara Therapeutics (CARA) Fair Value Target Lifted to $27 at Janney Capital
Tweet Send to a Friend
Janney Capital analyst Chiara Russo raised her fair value target on Cara Therapeutics (NASDAQ: CARA) to $27.00 (from $25.00) announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
